NIAID biodefense research agenda for category B and C priority pathogens.

Format:

Book

Government document

Contributor:

National Institute of Allergy and Infectious Diseases (U.S.)

Series:

NIH publication ; no. 03-5315.

NIH publication ; no. 03-5315

Language:

English

Subjects (All):

Vaccines--Biotechnology--Research--United States.

Vaccines.

Therapeutics--Research--United States.

Therapeutics.

Bioterrorism--prevention & control.

Biological Warfare--prevention & control.

Communicable Disease Control.

United States.

Therapeutics--Research.

Medical Subjects:

Bioterrorism--prevention & control.

Biological Warfare--prevention & control.

Communicable Disease Control.

United States.

Physical Description:

1 online resource.

Place of Publication:

[Bethesda, Md.] : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, [2003]

Summary:

The NIAID Biodefense Research Agenda for Category B and C Priority Pathogens builds on the Strategic Plan and provides recommendations relevant to the category B and C priority pathogens. As with the two previous research agendas, this document focuses on the need for basic research on the biology of the microbe, the host response, and basic and applied research aimed at the development of diagnostics, therapeutics, and vaccines against these agents.

Notes:

Title from PDF title screen (viewed on July 17, 2003).

"NIAID BIODEFENSE, preparing through research."

"January 2003."

Other Format:

Print version: NIAID biodefense research agenda for category B and C priority pathogens.

OCLC:

53286241